Magle PharmaCept as a part of Magle Group (Nasdaq Stockholm First North Growth Market: MAGLE) announces the publication of the final results of the prospective HepaStar trial, a multicenter observational trial evaluating the safety and effectiveness of EmboCept® S DSM 50 µm in the treatment of unresectable hepatocellular carcinoma (HCC). Hepatocellular carcinoma (HCC) is the […]
Magle Group is proud to announce that its approved the initiation of a multi-centre clinical trial to explore the use of EmboCept® S in Genicular Artery Embolisation (GAE), a minimally-invasive procedure aimed at delivering immediate and long-term pain relief for patients suffering from osteoarthritis (OA) of the knee. This innovative treatment, performed by interventional radiologists […]
Our team actively participated in the congress, diving deep into arterial interventions. Over the past few days, Helena Ossmer Thedius, Chief Marketing and Innovation Officer at Magle Group, and Franziska Sahm, Dr. Medical Affairs Manager at Magle PharmaCept, have attended highly informative meetings at CIRSE 2024. The congress provided an opportunity for participants to gain […]
Magle PharmaCept, a subsidiary of Magle Group, is pleased to announce the extension of its distribution agreement with its key distributor in the wound care field. The expanded agreement now includes strategic European territories, enhancing our reach and reinforcing our commitment to providing innovative wound care solutions across the region. AXXO® Woundgel, the brand owned […]
At Magle Group, our unwavering commitment to excellence drives us forward. Recently Magle Chemoswed announced the partnership with Dara Pharmaceutical Equipment, resulting in the acquisition of a state-of-the-art automated syringe filling and closing line. Our aspiration is to provide high quality healthcare innovations while constantly expanding our capabilities. With this remarkable addition, we’re taking a […]
At Magle PharmaCept, we are excited to announce our participation in the European Conference on Embolotherapy ET2024 Congress, in Vienna, where we gain Insights and focus on embolization in various areas. Attending sessions and connecting with partners and healthcare professionals broaden our understanding of user needs and create value for patients. collaboration between different specialties […]
Magle Group, through its subsidiary Magle PharmaCept, is excited to announce the appointment of a new distributor for SmartPAN® in Singapore. This strategic partnership represents a pivotal step in our efforts to introduce SmartPAN® to the Asian market, underlining our commitment to improving pancreatic surgery outcomes globally. Regulatory approval for SmartPAN® in Singapore is currently […]
Our team was participating in the 43rd Annual Meeting of the German Pancreas Club from February 15th – 17th, 2024. Our team members have been actively engaged in the Deutscher Pankreasclub lectures, poster sessions, and workshops, focusing on basic science breakthroughs in pancreatic cancer, along with the latest clinical and basic science innovations. The program […]
New study from Frankfurt University Hospital, Prof. Vogl has been published “Degradable Starch Microspheres Transarterial Chemoembolization with or without Lipiodol for Liver Metastases from Pancreatic Cancer: A Prospective Randomized Trial”. Check out the link below for the full article. Read More
Magle Group (Nasdaq Stockholm First North Growth Market: MAGLE) today 2023-09-08 16:05, announces the establishment of a collaboration and exclusive worldwide distribution agreement with the global medical device company Sirtex Medial pertaining to its chemoembolization product EmboCept® S DSM 50 µm. The main purpose is to accelerate internationalization, drive growth in new geographic areas, and […]
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. You also have the option to opt-out of these cookies. For more information about the cookies we use, see our Privacy Policy & Cookie Policy.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
